The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia

OBJECTIVE: Moderate and severe behavioral and psychological symptoms of dementia (BPSD) often need medical treatment to improve symptoms. Agomelatine is a selective melatonergic (MT1/MT2) agonist that has normalizing effects on disturbed circadian rhythms and disrupted sleep−wake cycles. Its activit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Carol Sheei-Meei, Cheng, Kuo-Sheng, Tang, Chia-Hung, Pai, Ming-Chyi, Chen, Pai-Lien, Chien, Pei-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606441/
https://www.ncbi.nlm.nih.gov/pubmed/36263645
http://dx.doi.org/10.9758/cpn.2022.20.4.701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606441/
https://www.ncbi.nlm.nih.gov/pubmed/36263645
http://dx.doi.org/10.9758/cpn.2022.20.4.701

Ejemplares similares